Hyderabad Telangana, India

Naresh Ghanta

This inventor holds 1 USPTO granted patent. Top assignee: Natco Pharma Limited. Active years: 2022.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Naresh Ghanta. Retrieved from https://idiyas.com/inventor/naresh-ghanta

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 8.0

ph-index = 1


Company Filing History:


Years Active: 2022

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Naresh Ghanta: Innovator in Pharmaceutical Chemistry

Introduction

Naresh Ghanta is a prominent inventor based in Hyderabad, Telangana, India. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of novel compounds. His work is characterized by a focus on improving processes for drug preparation.

Latest Patents

Naresh Ghanta holds a patent for the "Process for the preparation of ribociclib succinate and its novel crystalline forms thereof." This invention relates to an improved method for synthesizing the compound 7-cyclopentyl-N,N-dimethyl-2-{[5-(piperazin-1-yl)pyridin-2-yl]amino}-7H-pyrrolo[2,3-d]pyrimidine-6-carboxamide succinate (1/1), represented by the structural formula known as Formula-1a. This innovative process enhances the efficiency and effectiveness of drug formulation.

Career Highlights

Naresh Ghanta is associated with Natco Pharma Limited, a leading pharmaceutical company known for its commitment to research and development. His role at Natco Pharma has allowed him to contribute to various projects aimed at advancing pharmaceutical technologies.

Collaborations

Throughout his career, Naresh has collaborated with talented professionals, including Arunkumar Thiriveedhi and Swapna Kondaveeti. These collaborations have fostered a creative environment that encourages innovation and the sharing of ideas.

Conclusion

Naresh Ghanta's work exemplifies the spirit of innovation in the pharmaceutical industry. His contributions, particularly in the preparation of ribociclib succinate, highlight the importance of research in developing effective medications. His ongoing efforts continue to impact the field positively.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…